Drug or technology

Epinephrine

3 developments in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

Latest

Everything in the corpus, newest first.

AUG 19, 2026 · INTERVENTIONAL STUDY

Dopamine Versus Epinephrine for Pediatric Fluid-Refractory Hypotensive Septic Shock

ClinicalTrials.gov

This is a completed registry record for a 66-child randomized trial comparing dopamine and epinephrine in pediatric septic shock, but the source reports NO RESULTS, only the study design and planned outcomes.

PreliminaryEpinephrine Septic Shock Nishtar Medical University

Reported

Sample size66

Allocation ratio1:1

Per-arm sample size33

JUN 22, 2026 · REGULATORY LABEL UPDATE

FDA supplemental approval: Adrenalin (Labeling)

U.S. Food and Drug Administration

FDA supplemental approval for labeling changes to an established epinephrine product; does not report clinical trial outcomes or comparative efficacy data.

Regulatory UpdateEpinephrine PH Health

Reported

Approval status date2026-06-22

Product concentration1 mg/mL

MAR 30, 2026 · REGULATORY APPROVAL

FDA approval: Epinephrine (New Combination and New Formulation or New Manufacturer)

U.S. Food and Drug Administration

FDA approval of a new formulation and manufacturer of epinephrine; this is a regulatory action, not a clinical efficacy study, and does not establish comparative clinical benefit.

Regulatory UpdateEpinephrine Baxter Hlthcare

Reported

Approval date2026-03-30

Formulation 1 concentration30 mg/30 mL (1 mg/mL)

Formulation 2 concentration1 mg/mL